What
if you could learn about your health with a simple test, one that could
give you realistic and reasonable recommendations to promote your
quality of life? Would you take it? A current Time.com article,What Your Doctor Isn’t Telling You About Your DNA by Bonnie Rochman poses the question, should doctors share the bad news if they test a child's DNA and find that the child possesses a genetic mutation that may cause a health challenge later in life? It is one of those questions that can be debated back and forth because there are NO right or wrong answers. However, what most people don't know, is that there IS a simple and painless way for anybody to check their genetics...so that people can take action in accordance to their DNA.
When
it comes to our bodies, we want to make choices that have a positive
impact on our health. But some of those decisions – eating the wrong
foods, making certain lifestyle choices, even the way we exercise –
could impact our body's ability to maintain optimum health. Even if we
think we’re making the right choices, there are other factors that help
determine our overall picture of health.
Genetics
play a huge role in how our bodies process nutrients, how they respond
to activity and how we react to our environment and surroundings. When
it comes to your health, the answers are in your genes. Your DNA tells a
story: how you process foods, how you react to exercise, how your
environment affects your body, how your family history plays a part in
your health.
What
if you could learn about your health with a simple test, one that could
give you realistic and reasonable recommendations to promote your
quality of life? It’s time to make informed decisions about your health –
no more guesswork, just facts.
The
Gene SNP DNA Analysis combines your individual diet, lifestyle and
environment information and is scientifically merged with your genetic
background to provide an exclusive Health Action Plan designed
specifically for you. It will help provide practical suggestions
intended to promote your health and wellness. Based on variations in
your DNA and lifestyle factors, the Gene SNP DNA Analysis will make
recommendations based on how your body metabolizes food, utilizes
nutrients, removes toxins and responds to physical activity. By
understanding how your genetic profile affects your well-being, the Gene
SNP DNA Analysis will help you take charge of optimizing your wellness.
The Gene SNP DNA Analysis examines a wide variety of genes and SNPs,
providing a customized Health Action plan that focuses on diet,
nutrition, exercise and supplementation based on your genetic
profile.
Now
you can be sure your personalized Health Action Plan includes the best
possible supplementation thanks to the integration of the most advanced
nutraceutical products available, Isotonix. Each product has been
carefully chosen to provide you with the best supplementation based on
your individualized Health Action Plan. By integrating the Gene SNP DNA
Analysis with the Isotonix product line, you’ll be receiving the very
best supplementation support to maintain the healthiest of lifestyles.
No
longer will you have to accept a “one-size-fits-all” vitamin and
nutrition regimen. Using our exclusive patent rights to screen genetic
variations, Gene SNP DNA Analysis uncovers the ability of your genes to
respond to nutritional and environmental factors that affect various
areas of your health.
The
best part is that the results remain accurate throughout your life
since your gene makeup does not change. Since your genes don’t change,
you have the ability to optimize the function of your genes through
diet, exercise and nutritional supplementation. And while you can’t
change your genes, you can change your lifestyle. As you progress
through your Health Action Plan, following the recommendations
specifically suited for you and your body, you can make changes to your
online customer profile and receive an updated Health Action Plan with
recommendations based on your new, healthier lifestyle.
Frequently Asked Questions About the Gene SNP™ DNA Analysis:
What is the Gene SNP DNA Analysis?
The
Gene SNP DNA Analysis is a comprehensive kit that provides a laboratory
analysis of specific gene variants in your genetic material (DNA) that
have been found to influence health and an Online Customer Profile
survey that provides valuable information about various lifestyle habits
that relate to the gene variants being tested. These two pieces of
information are then analyzed together to provide you with a
personalized Health Action Plan outlining diet, nutrition, exercise and
supplementation recommendations.
Who should use this product?
Everyone
over the age 18 concerned about how their genetic makeup plays a role
in diet, nutrition and exercise should use this product.
How can understanding your genes promote a long, healthy life?Your
health is a result of interactions between your genes and lifestyle
factors such as diet, exercise, stress, smoking and alcohol. It is your
genetic makeup that determines which nutrients are utilized, how they
are used, the way toxins are removed and how effective these key
processes are within the body. The best part is that the results remain
accurate throughout your life since your gene makeup does not change.
Since your genes don’t change, you have the ability to optimize the
functioning of your genes through diet, exercise and nutritional
supplementation. And while you can’t change your genes, you can change
your lifestyle. As you progress through your Health Action Plan,
following the recommendations specifically suited for you and your body,
you can make changes to your online customer profile and receive an
updated Health Action Plan with recommendations based on your new,
healthier lifestyle.
Can I alter my genes through diet or lifestyle, or by using a vaccine?
No
matter what we do, our genes remain the same throughout our
lifetime. No amount of food or exercise can physically alter our genes.
With proper nutritional supplementation and lifestyle changes, you can
maintain the functioning of your gene variations to maintain optimal
health.
Will you be able to tell me if I’m ill?
No,
we can only determine what types of genes people have and how they
relate to certain metabolic factors involved in well-being. If you think
you may be ill, you should consult your doctor.
What is included in the Gene SNP DNA Analysis?
Your Gene SNP DNA Analysis kit includes:
- Access to a secure Online Customer Profile
- Bubble envelope
- Pre-addressed return FedEx stamp for the envelope
- Two swabs
- One small paper envelope
- Gene SNP booklet
- Consent form, Genetic Assessment Request Form, instructions and Gene SNP Code wallet-card
What do I do with the Consent and the Genetic Assessment Forms?
Both
forms have to be filled out and signed before the laboratory can accept
your swabs for processing and DNA analysis. Send the completed forms
with your swabs in the padded envelope using the prepaid shipping label
to the laboratory.
How does the Gene SNP DNA Analysis testing process work?
In
the privacy of your home, you simply use a mouth swab to collect cheek
cells, which contain your DNA. The swabs are put into the white swab
envelope provided after drying. Send the swabs with the Genetic
Assessment Request Form and the Consent Form in the padded envelope with
a prepaid shipping label provided in the kit to the processing
laboratory. Once at our certified laboratory, DNA is extracted from your
swabs and then prepared for analysis. The DNA is analyzed using the
latest genotyping technology to give the most accurate results. Your DNA
analysis is then matched with the answers you provided into the Online
Customer Profile. Once all of this data is compiled, it is entered into a
sophisticated, algorithm-based computer software program that generates
your confidential, easy-to-follow Gene SNP Health Action Plan.
How long does it take to get my Gene SNP DNA Analysis results?
Typically, it takes three to four weeks for you to receive your Gene SNP Health Action Plan.
How accurate are the results of my Gene SNP analysis?
The
analysis of your DNA is in compliance with the Quality Assurance and
Accuracy Verification Standards of the CLIA certified laboratory. The
accuracy of the genetic analysis is greater than 95 percent.
How can my sample fail the Gene SNP DNA Analysis?
Sometimes
the sample provided does not contain enough DNA because you just
brushed your teeth, or if you did not let the swabs dry long enough
before putting the swabs in the envelope, or if it took too long (longer
than 10 days) to reach the laboratory for analysis. It is important to
follow the Swab instructions in your kit.
How is my privacy protected?
Protecting
your privacy is at the core of Gene SNP DNA Analysis. We recognize your
need for strong privacy protection and the careful management of your
personal information. Any information you share is kept strictly
confidential and is secured electronically using sophisticated
encryption technology. The laboratory personnel and others who are
required in the processing of your genetic results have been trained and
tested to meet the requirements of Health Insurance Portability and
Accountability Act (HIPAA). Your results are handled as Protected Health
Information (PHI), as defined in HIPAA and regulations promulgated by
the U.S. Department of Health and Human Services in accordance to that
defined in 45 CFR, §160 and Subparts A and E of §164.
Should I worry about privacy issues?
Your
genetic information will be encrypted and will not be directly
associated with your personal information collected from your Online
Customer Profile, but will be stored in a database maintained in
accordance to CLIA and HIPAA standards. While this information may be
used by the laboratory research affiliates to conduct further analyses
for commercial purposes, under no conditions will this information be
released to third parties in a way that discloses personal information,
except with your written permission, unless required by law. The
laboratory is vigilant against breaches of security and improves
security and privacy safeguards on a regular basis.
Can I use my PCID to allow more than person to take the Online Customer Profile?
No,
the PCID number is used to authenticate a unique person who is logging
on and is used to identify specifically the supplements recommended for
that person.
Does my Gene SNP DNA Analysis Kit have an expiration date?You
must send in your cheek swabs, consent forms and complete your Online
Customer Profile within 180 days of the date the kit was purchased. All
sales of the Gene SNP DNA Analysis kit are final.
Scientific Studies Which Support the Gene SNP™ DNA Screening Analysis:
Genes
associated with cholesterol metabolism, triglyceride balance, vascular
flow and tissue development: APOC3, IL-6, eNOS, LPL, CETP, MTHFR:
- Brousseau,
M.E., et al, Cholesteryl ester transfer protein TaqI b2b2 Genotype is
associated with higher HDL cholesterol levels and lower risk of coronary
heart disease end points in men with HDL deficiency: Veterans Affairs
HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 22,
1148-1154 (2002)
- Brull, D.J., et al,
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are
strong predictors of plasma interleukin-6 levels after coronary artery
bypass surgery. Arterioscler Thromb Vasc Biol 21, 1458-1463 (2001)
- Brull,
D.J., et al, The effect of the Interleukin-6-174G > C promoter gene
polymorphism on endothelial function in healthy volunteers. Eur J Clin
Invest 32, 153-157 (2002)
- Chen, W. et al,
Combined effects of endothelial nitric oxide synthase gene polymorphism
(G894T) and insulin resistance status on blood pressure and familial
risk of hypertension in young adults: the Bogalusa Heart Study. Am J
Hypertens 14, 1046-1052 (2001)
- Dullaart,
R.P., et al, Cholesteryl ester transfer protein gene polymorphism is a
determinant of HDL cholesterol and of the lipoprotein response to a
lipid-lowering diet in type 1 diabetes. Diabetes 46, 2082-2087 (1997)
- Leeson,
C.P., Glu298Asp endothelial nitric oxide synthase gene polymorphism
interacts with environmental and dietary factors to influence
endothelial function. Circ Res 90, 1153-1158 (2002)
- Miyamoto,
Y., et al, Endothelial nitric oxide synthase gene is positively
associated with essential hypertension. Hypertension 32, 3-8 (1998)
- Shoji,
M., et al, Positive association of endothelial nitric oxide synthase
gene polymorphism with hypertension in northern Japan. Life Sci 66,
2557-2562 (2000)
- Brown, C.A., et al, A
common polymorphism in methionine synthase reductase increases risk of
premature coronary artery disease. J Cardiovasc Risk 7, 197-200 (2000)
- Christensen,
B., et al, Genetic polymorphisms in methylenetetrahydrofolate reductase
and methionine synthase, folate levels in red blood cells, and risk of
neural tube defects. Am J Med Genet 84, 151-157 (1999)
- Chen,
J, et al, A methylenetetrahydrofolate reductase polymorphism and the
risk of colorectal cancer. Cancer Res 56, 4862-4864 (1996)
- Jacques,
P.F., et al, Relation between folate status, a common mutation in
methylenetetrahydrofolate reductase, and plasma homocysteine
concentrations. Circulation 93, 7-9 (1996)
- Ma,
J., et al, Methylenetetrahydrofolate reductase polymorphism, dietary
interactions, and risk of colorectal cancer. Cancer Res 57, 1098-1102
(1997)
- Martinez de Villarreal, L.E., et
al, Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase
genotype (MTHFR) in mothers of offspring with neural tube defects: a
case-control study. Arch Med Res 32, 277-282 (2001)
- Slattery,
M.L., et al, Methylenetetrahydrofolate reductase, diet, and risk of
colon cancer. Cancer Epidemiol Biomarkers Prev 8, 513-518 (1999)
- Brown,
S., et al. Interaction between the APOC3 gene promoter polymorphisms,
saturated fat intake and plasma lipoproteins. Atherosclerosis. 170:
307-313, 2003.
- Fisher, R., et al. Common
variation in the lipoprotein lipase gene effects on plasma lipids and
risk of atherosclerosis. Atherosclerosis. 135: 145-159, 1997.
- Guzik,
T., et al. Relationship between the G894T (Glu298Asp variant) in
endothelial nitric oxide synthase and nitric oxide-mediated endothelial
function in human atherosclerosis. American Journal of Medical Genetics.
100: 130-137, 2001.
- Wallace, A., et al.
Variants in the cholesterol ester transfer protein and lipoprotein
lipase genes are predictors of plasma cholesterol response to dietary
change. Atherosclerosis. 152: 327-336, 2000.
Genes associated with antioxidant function and detoxification: MnSOD, SOD3, GSTM1, GSTT1, GSTP1:
- Ambrosone,
C.B., et al, Manganese superoxide dismutase 9MsSOD) genetic
polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer
Res 59(3), 602-606 (1999)
- Hirvonen, A, et
al, Association between manganese superoxide dismutase (MsSOD) gene
polymorphism and breast cancer risk. Carcinogenesis 5(22), 827-829
(2001)
- Kimura, K.Y., et al, Genetic
association of manganese superoxide dismutase with exudative age-related
macular degeneration. Am J Ophthalmol 130(6), 769-73 (2000)
- Stoehlmacher,
J., et al, A genetic polymorphism of manganese superoxide dismutase
(9MnSOD) predicts for risk of colorectal cancer in young individuals.
Annals of Oncology 11(Suppl 4), 59 (2000)
- Wang,
X.L., et al, Plasma extracellular cuperoxide dismutase levels in an
Australian population with coronary artery disease. Arterioscler Thromb
Vasc Biol 18, 1915-1921 (1998)
- Purdie, D.,
et al, Dietary antioxidants, manganese superoxide dismutase (MnSOD),
and risk of epithelial ovarian cancer. Proc. American Assoc. for Cancer
Res. 43, 4227 (2002)
- Cotton, S.C., et al,
Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE
review. Am J Epidemiol 151(1), 7-32 (2000)
- Lampe,
J.W., et al, Modulation of human glutathione S-transferases by
botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev 8,
787-93
- Lin, H.J., et al, Glutathione transferase GSTT1, broccoli, and prevalence of colorectal adenomas. Pharmacogenetics 12, 175-179
- Mitrunen,
K.N., et al, Glutathione S-transferase M1, M3, P1, and T1 genetic
polymorphisms and susceptibility to breast cancer. Cancer Epidemiol
Biomarkers Prev 10(3), 229-36 (2001)
- Pool-Zobul,
B, et al, Mechanisms by which vegetable consumption reduces genetic
damage in humans. Cancer Epidemiol. Biomarkers Prev. 7, 891-99 (1998)
- Rock, C.L., et al, Nutrition genetics and risks of cancer. Annu Rev Public Health 21, 47-64 (2000)
- Steinkellner,
H., et al, Effects of crusiferous vegetables and their constituents on
drug metabolizing enzymes involved in the bioactivation of DNA-reactive
dietary carcinogens. Mutation Research, 480-481,285-297 (2001)
- Ambrosone,
C., et al. Manganese superoxide dismutase (MnSOD) genetic
polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer
Research. 59(3): 602-606, 1999.
- Chistyakov,
D. A., et al. Polymorphisms in the Mn-SOD and EC-SOD genes and their
relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC
Medical Genetics. 2(1): 4, 2001.
- Parke, D.V. “Antioxidants and disease prevention: mechanisms of action”. Antioxidants in Human Health. CABI Publishing, 1999.
- Gaudet, M., et al. Diet, GSTM1, and GSTT1 and head and neck cancer. Carcinogenesis. 25(5): 735-740, 2003
- Lampe,
J.W., et al. Modulation of human glutathione S-transferases by
botanically defined vegetable diets. Cancer Epidemiology Biomarkers
Preview. 9(8):787-793, 2000.
- Verhoeff, B.,
et al. The effect of a common methylenetetrahydrofolate reductase
mutation on levels of homocysteine, folate, vitamin B12 and on the risk
of premature atherosclerosis. Atherosclerosis. 141(1): 161-166, 1998
- Change,
A., et al. The effect of 677 C T and 1298 A C mutations on plasma
homocysteine and 5,10- methylenetetrahydrofolate reductase activity in
healthy subjects. British Journal of Nutrition. 83(6): 593-596, 2000.
- Jacques,
P., et al. Relation between folate status, a common mutation in
methylenetetrahydrofolate reductase, and plasma homocysteine
concentrations. Circulation. 93(1): 7-9, 1996.
- Miller
M., and Mohrenweiser, H. Genetic variability in susceptibility and
response to toxicants. Toxicology Letters. 120(1-3): 269-280, 2001.
- Cosma,
G., et al. Relationship between genotype and function of the human
CYP1A1 gene. Journal of Toxicology and Environmental Health. 40(2-3):
309-316, 1993.
- Bosron, W. and Ting-Kai, L.
Genetic polymorphism of human liver alcohol and aldehyde
dehydrogenases, and their relationship to alcohol metabolism and
alcoholism. Hepatology. 6(3):502 - 510, 1986.
- Takeshita,
T. and Morimoto, K. Accumulation of hemoglobin-associated acetaldehyde
with habitual alcohol drinking in the atypical ALDH2 genotype. Alcohol
Clinical and Experimental Research. 24(1): 1-7, 2000.
Genes associated with bone structure: VDR, COL1A1, IL6, TNFα:
- Chen,
H.Y., et al, Relation of vitamin D receptor FokI start codon
polymorphism to bone mineral density and occurrence of osteoporosis in
postmenopausal woman in Taiwan. Acta Obstet Gynecol Scan 81, 93-98
(2002)
- Dennison, E.M., at al, Birthweight,
vitamin D receptor genotype and the programming of osteoporosis.
Paediatr Perinat Epidemiol 15, 211-219 (2001)
- Eastell, R. and Lambert, H., Diet and healthy bones., Calcif Tissue Int 70, 400-404 (2002)
- Ferrari,
S., et al, Bone mineral mass and calcium and phosphate metabolism in
young men: relationships with vitamin D receptor allelic polymorphisms. J
Clin Endocrinol Metab 84, 2043-2048 (1999)
- Ferrari. S.L., Osteoporosis, vitamin D receptor gene polymorphisms and response to diet. World Rev Nutr Diet 89, 83-92 (2001)
- Garnero,
P., et al, Association between a functional interleukin-6 gene
polymorphism and peak bone mineral density and postmenopausal bone loss
in women: the ofely study. Bone 31, 43-50 (2002)
- Gong,
G., et al, The association of bone mineral density with vitamin D
receptor gene polymorphisms. Osteoporos Int 9, 55-64 (1999)
- Lorentzon,
M., et al, Vitamin D receptor gene polymorphism is related to bone
density, circulating osteocalcin, and parathyroid hormone in healthy
adolescent girls. J Bone Miner Metab 19, 302-307
- MacDonald,
H.M., et al, COL1A1 Sp1 polymorphism predicts perimenopausal and early
postmenopausal spinal bone loss. J Bone Miner Res 16, 1634-1641 (2001)
- Mann,
V., et al, A COL1A1 Sp1 binding site polymorphism predisposes to
osteoporotic fracture by affecting bone density and quality. J Clin
Invest 107, 899-907 (2001)
- Prentice, A., The relative contribution of diet and genotype to bone development. Proc Nutr Soc 60, 45-52 (2001)
- Ralston, S.H., Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87, 2460-2466 (2002)
- Grant,
S., et al. Reduced bone density and osteoporosis associated with a
polymorphic Sp1 binding site in the collagen type 1 alpha 1 gene. Nature
Genetics. 14: 203-205, 1996.
- Ortlepp, J.,
et al. The vitamin D receptor gene variant and physical activity
predicts fasting glucose levels in healthy young men. Diabetic Medicine.
20: 451-454, 2003.
- Uitterlinden, A., et
al. Interaction between the vitamin D receptor gene and collagen type
1alpha1 gene susceptibility for fracture. Journal of Bone and Mineral
Research. 16: 379-385, 2001.
Genes associated with inflammatory response: TNF, IL-6:
- Abraham,
L.J., et al, Impact of the -308 TNF promoter polymorphism on the
transcriptional regulation of the TNF gene: relevance to disease. J
Leukoc Biol 66, 552-566 (1999)
- Chung,
H.Y., et al, The inflammation hypothesis of aging: molecular modulation
by calorie restriction. Ann NY Acad Sci 928, 327-335 (2001)
- Grimble, R.F., Nutritional modulation of immune function. Proc Nutr Soc 60, 389-397 (2001)
- Nakajima,
T., et al, Allelic variants in the interleukin-6 gene and essential
hypertension in Japanese women. Genes Immun 1, 115-119 (1999)
- Terry,
C.F., et al, Cooperative influence of genetic polymorphisms on
interleukin 6 transcriptional regulation. J Biol Chem 275, 18138-18144
(2000)
- Vickers, M.A., et al, Genotype at a
promoter polymorphism of the interleukin-6 gene is associated with
baseline levels of plasma C-reactive protein. Cardiovasc Res 53,
1029-1034 (2002)
- Ferrari, S., et al. Two
promoter polymorphisms regulating interleukin-6 gene expression are
associated with circulating levels of C-reactive protein and markers of
bone resorption in postmenopausal women. Journal of Clinical
Endocrinology & Metabolism. 88: 255-259, 2003.
- Grimble
R., et al. The ability of fish oil to suppress tumor necrosis factor
alpha production by peripheral blood mononuclear cells in healthy men is
associated with polymorphisms in genes that influence tumor necrosis
factor alpha production. American Journal of Clinical Nutrition. 76(2):
454-459, 2002.
- Terry, c., et al.
Cooperative influence of genetic polymorphisms on interleukin 6
transcriptional regulation. Journal of Biological Chemistry. 275:
18138-18144, 2000.
- Vendrell, J., et al. A
polymorphism in the promoter of the tumor necrosis factor-alpha gene
(-308) is associated with coronary heart disease in type 2 diabetic
patients. Atherosclerosis. 167: 257-264, 2003.
- Witte,
J.S., et al, Relation between tumour necrosis factor polymorphism
TNFalpha-308 and risk of asthma. Eur J Hum Genet 10, 82-85 (2002)
Genes associated with glucose balance: VDR, PPARg2, ACE, TNF:
- Chiu,
K.C., et al, The vitamin D receptor polymorphism in the translation
initiation codon is a risk factor for insulin resistance in glucose
tolerant Caucasians. BMC Med Genet 2,2 (2001)
- Dalziel,
B., et al, Association of the TNF-alpha -308G/A promoter polymorphism
with insulin resistance in obesity. Obes Res 10, 401-407 (2002)
- Deeb,
S.S., et al, A Pro12Ala substitution in PPARgamma2 associated with
decreased receptor activity, lower body mass index and improved insulin
sensitivity. Nat Genet 20, 284-287 (1998)
- Dengel,
D.R., et al, Exercise-induced changes in insulin action are associated
with ACE gene polymorphisms in older adults. Physiol Genomics 11, 73-80
(2002)
- Kadowaki, T., et al, The role
PPARgamma in high-fat diet-induced obesity and insulin resistance. J
Diabetes Complications 16, 41-45 (2002)
- Nicaud,
V., et al, The TNF alpha/G-308A polymorphism influences insulin
sensitivity in offspring of patients with coronary heart disease: the
European Atherosclerosis Research Study II. Atherosclerosis 161, 317-325
(2002)
- Paolisso, G., et al, ACE gene
polymorphism and insulin action in older subjects and healthy
centenarians. J Am Geriatr Soc 49, 610-614 (2001)
- Li,
S., et al. The peroxisome proliferator-activated receptor-gamma2 gene
polymorphism (Pro12Ala) beneficially influences insulin resistance and
its tracking from childhood to adulthood: the Bogalusa Heart Study.
Diabetes. 52: 1265-1269, 2003.
- Ostgren,
C., et al. Peroxisome proliferator-activated receptor-gammaPro12Ala
polymorphism and the association with blood pressure in type 2 diabetes:
Skaraborg hypertension and diabetes project. Journal of Hypertension.
21: 1657-1662, 2003.
- Paolisso, G., et al.
ACE gene polymorphism and insulin action in older subjects and healthy
centenarians. Journal of American Geriatric Society. 49: 610-614, 2001.
- Perticone,
F., et al. Relationship between angiotensin-converting enzyme gene
polymorphism and insulin resistance in never-treated hypertensive
patients. Journal of Clinical Endocrinology & Metabolism. 86:
172-178, 2001.
* These statements have not been evaluated by the Food and Drug Administration.
This product(s) is not intended to diagnose, treat, cure or prevent any disease.
Orlampa Enterprises, Inc.
specializes in helping individuals lose sickness and find wellness.
Orlampa Enterprises also
helps health care professionals implement holistic wellness programs into their
existing practice with the goal to educate both the health care provider and
the patient. The programs, which provide the health care professional with a
substantial additional income stream in this ever changing medical marketplace,
allow the patient to achieve true wellness instead of receiving a traditional
treatment for symptoms.
Orlampa Enterprises is an internet based product broker specializing in
personalized health and wellness related services. Orlampa Enterprises is
primed to continue its growth by duplicating its successful business model of
educating, training, and developing entrepreneurial leaders as business
partners. As an Unfranchise™ business owner, Orlampa Enterprises, proudly
utilizes highly researched products including nutraMetrix® nutritional
supplements.
Orlampa
Enterprises' motto is "Eat well, exercise, and supplement
intelligently."
Contact Beth at bb@orlampa.com or 727.492.8212 for more information about
nutraMetrix® partnership opportunities available.
